Shawn, I. H., & Jamiruddin, M. R. (2024). Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: A systematic review and meta-analysis. Brac University.
Chicago Style (17th ed.) CitationShawn, Ibna Hasan, and Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.
ציטוט MLAShawn, Ibna Hasan, and Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.